Highlights and Quick Summary
- Current Revenue (Deferred) for the quarter ending September 30, 2022 was $7.52 Million (a 4.56% increase compared to previous quarter)
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Current Revenue (Deferred) of BridgeBio Pharma, Inc.
Most recent Current Revenue (Deferred)of BBIO including historical data for past 10 years.Interactive Chart of Current Revenue (Deferred) of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Current Revenue (Deferred) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $7.52 | $7.19 | – | – | – |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology